New York State Teachers Retirement System Has $796,000 Stock Holdings in Sotera Health (NASDAQ:SHC)

New York State Teachers Retirement System lifted its stake in shares of Sotera Health (NASDAQ:SHC) by 8.7% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 58,173 shares of the company’s stock after buying an additional 4,673 shares during the quarter. New York State Teachers Retirement System’s holdings in Sotera Health were worth $796,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of SHC. Darsana Capital Partners LP lifted its stake in shares of Sotera Health by 716.9% during the 3rd quarter. Darsana Capital Partners LP now owns 20,010,000 shares of the company’s stock worth $334,167,000 after buying an additional 17,560,636 shares during the last quarter. Sessa Capital IM L.P. increased its position in Sotera Health by 46.5% during the third quarter. Sessa Capital IM L.P. now owns 6,300,597 shares of the company’s stock worth $105,220,000 after acquiring an additional 2,000,000 shares during the period. State Street Corp increased its position in Sotera Health by 18.5% during the third quarter. State Street Corp now owns 4,126,806 shares of the company’s stock worth $68,918,000 after acquiring an additional 644,236 shares during the period. Geode Capital Management LLC increased its position in Sotera Health by 19.4% during the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock worth $46,026,000 after acquiring an additional 447,186 shares during the period. Finally, Barclays PLC increased its position in Sotera Health by 169.8% during the third quarter. Barclays PLC now owns 473,597 shares of the company’s stock worth $7,909,000 after acquiring an additional 298,085 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Price Performance

SHC stock opened at $13.52 on Monday. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. Sotera Health has a 12 month low of $10.71 and a 12 month high of $17.44. The firm has a market cap of $3.83 billion, a P/E ratio of 54.08 and a beta of 1.91. The company’s 50-day moving average price is $13.45 and its two-hundred day moving average price is $14.56.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on SHC. The Goldman Sachs Group began coverage on shares of Sotera Health in a research report on Friday, December 6th. They set a “neutral” rating and a $14.00 price target on the stock. Barclays lowered their price target on shares of Sotera Health from $18.00 to $17.00 and set an “overweight” rating on the stock in a research report on Tuesday, February 18th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $17.00 price target on shares of Sotera Health in a research report on Thursday, November 21st. Finally, Citigroup raised their price target on shares of Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, Sotera Health has an average rating of “Moderate Buy” and a consensus target price of $16.08.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.